Ardent Health Partners Stock Earnings Reports

Ardent reported a strong start to 2026 with revenue of $1.6 billion (up 7%) and adjusted EBITDA of $124 million (up 26%; +15% excluding a $10.9M pre-tax one-time investment gain). Adjusted admissions grew 2% (midpoint of guidance) and total surgeries rose 1.2% (outpatient surgery +1.7%). The company highlighted continued progress on its IMPACT cost-savings program, reaffirming a $55 million savings target for 2026, with notable wins in labor (salaries, wages & benefits per adjusted admission down; contract labor down >40% to $15M, now ~2.2% of SW&B) and supply chain (rebates, vendor rationalization and renegotiated distribution contracts). Ardent is advancing outpatient/ambulatory growth (urgent cares, ASCs, a freestanding ED), is deploying AI-driven virtual care (hellocare.ai across ~2,000 rooms) to improve safety and efficiency, and remains disciplined on capital deployment. Balance sheet: cash $610M, total debt $1.1B, total available liquidity ~$0.9B, net leverage 1.0x (lease-adjusted 2.6x). Management says payer denials stabilized, professional fees are tracking to plan (expected to moderate to high single digits later in the year), and exchange-related mix/metal shifts remain a headwind (previously estimated ~$35M impact). Company reaffirmed full-year revenue and adjusted EBITDA guidance and emphasized focus on controllable factors: cost discipline, operational execution, and capital allocation.